LC-MS Metabolomics Comparisons of Cancer Cell and Macrophage Responses to Methotrexate and Polymer-encapsulated Methotrexate

Overview

Journal Int J Pharm X

Specialty Pharmacology

Date 2020 Jan 30

PMID 31993584

Citations 6

Authors

Mohammad Ahmad Al-Natour

Ali Alazzo

Amir M Ghaemmaghami

Dong-Hyun Kim

Cameron Alexander

Affiliations

Soon will be listed here.

Abstract

Methotrexate (MTX) is a folate analogue antimetabolite widely used for the treatment of rheumatoid arthritis and cancer. A number of studies have shown that MTX delivered via nanoparticle carriers is more potent against cancer cells than free MTX, a phenomenon attributed to higher cellular uptake of the particles compared to the saturable folate receptor pathway. In this study, a cell-based global metabolic profiling approach was applied to study the effects of MTX in both free drug form and when encapsulated in -poly(lactide-co-glycolide) (PLGA) nanoparticles on a cancer cell line, A549, and also on human-like THP-1 macrophages. The results showed that MTX loaded nanoparticles had less impact on the macrophages than free MTX, and the effects on macrophages were limited to changes in nucleotide metabolism and suppression of the tricarboxylic acid cycle, whereas free MTX also led to a drop in glycolytic activity and impairment in redox homeostasis. In contrast, MTX loaded nanoparticles showed a greater impact on A549 cells than the free drug, which was in accord with studies in other cell lines in prior literature with MTX-carrier nanoparticles.

Citing Articles

SERSomes for metabolic phenotyping and prostate cancer diagnosis.

Bi X, Wang J, Xue B, He C, Liu F, Chen H Cell Rep Med. 2024; 5(6):101579.

PMID: 38776910 PMC: 11228451. DOI: 10.1016/j.xcrm.2024.101579.

The toxicity of nanoparticles and their interaction with cells: an metabolomic perspective.

Awashra M, Mlynarz P Nanoscale Adv. 2023; 5(10):2674-2723.

PMID: 37205285 PMC: 10186990. DOI: 10.1039/d2na00534d.

Taste Masking of Promethazine Hydrochloride Using l-Arginine Polyamide-Based Nanocapsules.

Alyami H, Ali D, Jarrar Q, Jaradat A, Aburass H, Mohammed A Molecules. 2023; 28(2).

PMID: 36677806 PMC: 9865149. DOI: 10.3390/molecules28020748.

Tumor Targeting with Methotrexate-Conjugated Zwitterionic Near-Infrared Fluorophore for Precise Photothermal Therapy.

Jo G, Kim E, Park M, Hyun H Int J Mol Sci. 2022; 23(22).

PMID: 36430604 PMC: 9697011. DOI: 10.3390/ijms232214127.

Metabolic Signatures of Surface-Modified Poly(lactic--glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics.

Al-Natour M, Abdelrazig S, Ghaemmaghami A, Alexander C, Kim D ACS Omega. 2022; 7(33):28806-28819.

PMID: 36033713 PMC: 9404530. DOI: 10.1021/acsomega.2c01660.

References

Scheltema R, Jankevics A, Jansen R, Swertz M, Breitling R . PeakML/mzMatch: a file format, Java library, R library, and tool-chain for mass spectrometry data analysis. Anal Chem. 2011; 83(7):2786-93. DOI: 10.1021/ac2000994. View

Alazzo A, Al-Natour M, Spriggs K, Stolnik S, Ghaemmaghami A, Kim D . Investigating the intracellular effects of hyperbranched polycation-DNA complexes on lung cancer cells using LC-MS-based metabolite profiling. Mol Omics. 2019; 15(1):77-87. DOI: 10.1039/c8mo00139a. View

Richter E, Ventz K, Harms M, Mostertz J, Hochgrafe F . Induction of Macrophage Function in Human THP-1 Cells Is Associated with Rewiring of MAPK Signaling and Activation of MAP3K7 (TAK1) Protein Kinase. Front Cell Dev Biol. 2016; 4:21. PMC: 4811913. DOI: 10.3389/fcell.2016.00021. View

Lonnerholm G, Valsecchi M, De Lorenzo P, Schrappe M, Hovi L, Campbell M . Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2009; 52(5):596-601. DOI: 10.1002/pbc.21925. View

Quemeneur L, Gerland L, Flacher M, Ffrench M, Revillard J, Genestier L . Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides. J Immunol. 2003; 170(10):4986-95. DOI: 10.4049/jimmunol.170.10.4986. View

Vander Heiden M, Cantley L, Thompson C . Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009; 324(5930):1029-33. PMC: 2849637. DOI: 10.1126/science.1160809. View

Bohm I . Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them. Biomed Pharmacother. 2004; 58(5):338-43. DOI: 10.1016/j.biopha.2004.04.010. View

Singh R, Fouladi-Nashta A, Li D, Halliday N, Barrett D, Sinclair K . Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation. J Cell Biochem. 2006; 99(1):146-55. DOI: 10.1002/jcb.20908. View

Creek D, Jankevics A, Burgess K, Breitling R, Barrett M . IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data. Bioinformatics. 2012; 28(7):1048-9. DOI: 10.1093/bioinformatics/bts069. View

10.

Gulfam M, Matini T, Monteiro P, Riva R, Collins H, Spriggs K . Bioreducible cross-linked core polymer micelles enhance in vitro activity of methotrexate in breast cancer cells. Biomater Sci. 2017; 5(3):532-550. DOI: 10.1039/c6bm00888g. View

11.

McBride A, Antonia S, Haura E, Goetz D . Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature. J Pharm Pract. 2012; 25(4):477-85. DOI: 10.1177/0897190012442717. View

12.

Wessels J, Huizinga T, Guchelaar H . Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2007; 47(3):249-55. DOI: 10.1093/rheumatology/kem279. View

13.

Nicholson J, Lindon J . Systems biology: Metabonomics. Nature. 2008; 455(7216):1054-6. DOI: 10.1038/4551054a. View

14.

Sumner L, Amberg A, Barrett D, Beale M, Beger R, Daykin C . Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics. 2013; 3(3):211-221. PMC: 3772505. DOI: 10.1007/s11306-007-0082-2. View

15.

van Dalen E, de Camargo B . Methotrexate for high-grade osteosarcoma in children and young adults. Cochrane Database Syst Rev. 2009; (1):CD006325. DOI: 10.1002/14651858.CD006325.pub2. View

16.

Tautenhahn R, Bottcher C, Neumann S . Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics. 2008; 9:504. PMC: 2639432. DOI: 10.1186/1471-2105-9-504. View

17.

Want E, Wilson I, Gika H, Theodoridis G, Plumb R, Shockcor J . Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc. 2010; 5(6):1005-18. DOI: 10.1038/nprot.2010.50. View

18.

Batrakova E, Li S, Brynskikh A, Sharma A, Li Y, Boska M . Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release. 2010; 143(3):290-301. PMC: 3089980. DOI: 10.1016/j.jconrel.2010.01.004. View

19.

Brody M, Bohm I, Bauer R . Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells. Eur J Clin Chem Clin Biochem. 1993; 31(10):667-74. DOI: 10.1515/cclm.1993.31.10.667. View

20.

Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M . Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2013; 42(Database issue):D199-205. PMC: 3965122. DOI: 10.1093/nar/gkt1076. View